Skip to main content
Clinical Trials/CTRI/2023/08/056098
CTRI/2023/08/056098
Not yet recruiting
Phase 3

Efficacy of indigenous High Flow Nasal Cannula (HFNC) device in acute hypoxemic respiratory failure when compared to standard HFNC device - NI

Amrita Institute of Medical Sciences0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: J960- Acute respiratory failure
Sponsor
Amrita Institute of Medical Sciences
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. The eligibility criteria for this study would be (1\) Inborn babies with respiratory distress (clinical / laboratory)
  • 2\. RSS Mild to moderate
  • 3\. SPO2 \<\= 94% on low\-flow oxygen therapy or needs a high\-flow device
  • 4\. In preterm 88\-92% ( \< 28 weeks)
  • 5\. Signs of increased work of breathing on low oxygen

Exclusion Criteria

  • RSS scoring: Severe respiratory distress
  • Underlying hemodynamic instability
  • Congenital heart disease which is critical
  • midfacial anomalies prohibiting the use of nasal cannula and
  • those requiring immediate intubation and ventilation because of apnea, respiratory failure, or profound hypoxemia
  • Do not Resuscitate (DNR)

Outcomes

Primary Outcomes

Not specified

Similar Trials